In December 2008, the European Competitiveness Council recognized the need to launch a pilot joint programming initiative dedicated to combating neurodegenerative diseases in the context of the major societal challenges facing Europe, including the aging of its population. The JPND – EU Joint Program – Neurodegenerative Disease Research initiative emerged as the response to this challenge.
The following countries are members of JPND: Albania; Germany; Australia; Austria; Belgium; Bulgaria; Canada; Croatia; Denmark; Slovakia; Slovenia; Spain; Finland; France; Greece; Hungary; Ireland; Israel; Italy; Luxembourg; Norway; Netherlands; United Kingdom; Czech Republic; Poland; Portugal; Romania; Sweden; Switzerland; Turkey.
JPND activities
The activities of the JPND, particularly Calls research projects, are based on the provisions of its Research and Innovation Agenda, the first version of which was launched in 2012. The new version of the JPND Strategic Research and Innovation Agenda was published on April 23, 2019, and its research priorities are: origins and progression of neurodegenerative diseases; disease mechanisms and models; diagnosis, prognosis, and disease definitions; development of therapies, preventive strategies, and interventions; and social and health care. The agenda includes a range of activities that enable these priorities to be implemented in a broad and comprehensive manner, aligning scientific expertise and different social approaches in the participating countries in order to avoid duplication of effort.
The implementation of JPND has been supported over the years by the European Commission through the funding of coordination and support actions and ERA-NETs under various framework programs for research and innovation. Currently, this initiative is supported by the JPco-fuND (2014-2019), JPsustaiND (2015-2019), and JPcofuND2 (2019-2023), with funds from the 8th H2020 framework program.
-
State
Active
-
Website
-
Contacts
-
Share
